{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":5,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":5,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"f99a8f61fe61","filters":{"venue":"Video Journal of Biomedicine"}},"results":[{"id":"W4407771126","doi":"10.1080/vjbm-2024-0012","title":"Spesolimab Treatment for the Prevention of Flares in People with Generalized Pustular Psoriasis (GPP): A Video Summary of the EFFISAYIL® 2 Study","year":2025,"lang":"en","type":"article","venue":"Video Journal of Biomedicine","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Generalized pustular psoriasis; Psoriasis; Medicine; Dermatology; Pustular psoriasis","authors":[{"name":"Akimichi Morita","is_ca":false},{"name":"Slaheddine Marrakchi","is_ca":false},{"name":"Na Hu","is_ca":true},{"name":"Christian Thoma","is_ca":false},{"name":"Min Zheng","is_ca":false},{"name":"Tsen‐Fang Tsai","is_ca":false},{"name":"Mark Lebwohl","is_ca":false},{"name":"Milan J. Anadkat","is_ca":false},{"name":"Kenneth B. Gordon","is_ca":false},{"name":"Siew Eng Choon","is_ca":false},{"name":"A. David Burden","is_ca":false},{"name":"Thomas Haeufel","is_ca":false},{"name":"Diamant Thaçi","is_ca":false},{"name":"Bruce Strober","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01531226256697819,"gpt":0.2747713921648219,"spread":0.2594591295978437,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000752674,0.0005410732,0.00057384,0.0007043499,0.0002409546,0.0005671551,0.0003093849,0.0009938793,0.04239092],"category_scores_gemma":[0.001704431,0.0001535208,0.000907679,0.0005359363,0.00009728067,0.000344286,0.0002039142,0.001003185,0.004551551],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005765337,"about_ca_system_score_gemma":0.0004880599,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003786306,"about_ca_topic_score_gemma":0.009442317,"domain_scores_codex":[0.999705,0.00009808241,0.00002070083,0.00002132977,0.0001088408,0.00004599363],"domain_scores_gemma":[0.9992969,0.0003000858,0.0001154479,0.00001103722,0.0001249615,0.0001515859],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.005745467,0.0002875441,0.0007530726,0.004533927,0.0002459366,0.0003898316,0.00005349981,0.0001739091,0.001815316,0.0005463306,0.6272539,0.3582012],"study_design_scores_gemma":[0.01108521,0.006616406,0.0206515,0.006027139,0.0008961722,0.001625004,0.0001231071,0.000490659,0.002086771,0.001425772,0.9489024,0.00006985066],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"review","genre_gemma":"other","genre_scores_codex":[0.03045959,0.5208644,0.004525715,0.1271016,0.03324246,0.005398223,0.06288867,0.001029924,0.2144895],"genre_scores_gemma":[0.1506954,0.5025995,0.01664373,0.08032927,0.07098819,0.003328078,0.04689623,0.0004765414,0.1280431],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.04239092,"threshold_uncertainty_score":0.1418117,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4387459404","doi":"10.2217/vjbm-2023-0008","title":"Safety evaluation of empagliflozin for patients with type 2 diabetes and chronic kidney disease","year":2023,"lang":"en","type":"article","venue":"Video Journal of Biomedicine","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Providence Health Care","funders":"","keywords":"Empagliflozin; Type 2 diabetes; Medicine; Kidney disease; Diabetes mellitus; Intensive care medicine; Disease; Internal medicine; Endocrinology","authors":[{"name":"Katherine R. Tuttle","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01570695684960683,"gpt":0.2842323765379948,"spread":0.2685254196883879,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003953156,0.0002667771,0.0005633584,0.0004417833,0.000275692,0.0006739705,0.000285095,0.0008828865,0.003508955],"category_scores_gemma":[0.01153341,0.00009846191,0.001083286,0.0002930435,0.0002197752,0.0004623558,0.0002602127,0.001275221,0.000429105],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007263165,"about_ca_system_score_gemma":0.0007547332,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007029116,"about_ca_topic_score_gemma":0.0009971102,"domain_scores_codex":[0.9980775,0.0008310401,0.0001288338,0.0001317037,0.0007478687,0.00008302728],"domain_scores_gemma":[0.9941057,0.002525322,0.0009900235,0.0001688491,0.001740308,0.0004698826],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.05459874,0.001734405,0.03428921,0.002031165,0.001231849,0.0007108044,0.0001884305,0.0008888624,0.01502744,0.001035669,0.0538017,0.8344617],"study_design_scores_gemma":[0.04641672,0.2175499,0.2515965,0.004774624,0.00762273,0.01010048,0.0005596372,0.01526957,0.07896899,0.00492496,0.3618727,0.000343217],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.6847085,0.1418368,0.01850695,0.06717322,0.005460158,0.002548374,0.009330167,0.0008244153,0.06961154],"genre_scores_gemma":[0.9193003,0.02735254,0.01158536,0.0213286,0.005802102,0.0009118795,0.004188174,0.000089253,0.009441923],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003953156,"threshold_uncertainty_score":0.02090657,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4415877690","doi":"10.1080/vjbm-2025-0004","title":"Blood Biomarker Dynamics in People with Relapsing Multiple Sclerosis Treated with Cladribine Tablets: Results of the 2-Year MAGNIFY-MS Study","year":2025,"lang":"en","type":"article","venue":"Video Journal of Biomedicine","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Université de Montréal; St. Michael's Hospital","funders":"Merck KGaA","keywords":"Cladribine; Multiple sclerosis; Immune system; Biomarker; Immunotherapy","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.02764460158080831,"gpt":0.2761528758841976,"spread":0.2485082743033893,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005465533,0.0001814295,0.0004262977,0.0003503125,0.000300307,0.0003770074,0.0001278295,0.0005364597,0.001622504],"category_scores_gemma":[0.001336386,0.0001143826,0.0004197353,0.0003951434,0.00008342465,0.0003323868,0.00028464,0.0006199013,0.0003180317],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002582848,"about_ca_system_score_gemma":0.0002051207,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005111901,"about_ca_topic_score_gemma":0.00527129,"domain_scores_codex":[0.999867,0.00003464759,0.00001079949,0.0000292421,0.00003688389,0.00002149993],"domain_scores_gemma":[0.9994363,0.0001086441,0.0001462993,0.00002860907,0.0001567187,0.0001234254],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0113242,0.0009797288,0.9174287,0.0002895879,0.0004549953,0.001052269,0.001207556,0.0002416243,0.003565767,0.0001068476,0.009438048,0.05391071],"study_design_scores_gemma":[0.0001598533,0.001853544,0.9946545,0.00003314631,0.0001542426,0.000290527,0.0003780203,0.0001698594,0.0002491463,0.00004638728,0.001991217,0.00001955159],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9905204,0.001211094,0.0002502005,0.0004141962,0.00004590695,0.0000861133,0.005426079,0.0000309124,0.00201515],"genre_scores_gemma":[0.9924964,0.0007861391,0.0004840331,0.0003363144,0.00010348,0.0001092509,0.003919593,0.000007899098,0.001756805],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005111901,"threshold_uncertainty_score":0.01016432,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4313639990","doi":"10.2217/vjbm-2023-0001","title":"A plain language summary of the impact of vaccines against flu and chickenpox in people with multiple sclerosis treated with cladribine tablets","year":2023,"lang":"en","type":"article","venue":"Video Journal of Biomedicine","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Global Affairs Canada","funders":"Deutsche Forschungsgemeinschaft; EMD Serono; GW Pharmaceuticals; CSL Behring; Teva Pharmaceutical Industries; Bundesministerium für Bildung und Forschung; Biogen; Fresenius Medical Care North America; Celgene; Merck KGaA; Sanofi","keywords":"Cladribine; Multiple sclerosis; Medicine; Chickenpox; Immunology; Intensive care medicine; Virus; Internal medicine","authors":[{"name":"Klaus Schmierer","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02509706394990498,"gpt":0.2882615105151259,"spread":0.2631644465652209,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005137305,0.0005795123,0.0005440782,0.0009790885,0.0004520135,0.0008331585,0.0004053222,0.001090564,0.2606423],"category_scores_gemma":[0.005472507,0.0001266776,0.0006729763,0.0007847651,0.0001499862,0.0006638764,0.000388564,0.001308695,0.02654226],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000783687,"about_ca_system_score_gemma":0.0009169168,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00914361,"about_ca_topic_score_gemma":0.01198554,"domain_scores_codex":[0.9997645,0.00007142309,0.00002050584,0.00001633649,0.00008165887,0.0000456208],"domain_scores_gemma":[0.9974038,0.001306669,0.0002180781,0.00003248717,0.0006985064,0.0003404597],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002492492,0.00002757408,0.0002170647,0.0005398048,0.000009700557,0.0001503272,0.0000408253,0.00003147951,0.0001173673,0.0001549621,0.9808904,0.01757136],"study_design_scores_gemma":[0.0003911499,0.0004371656,0.006733281,0.002357587,0.0000477749,0.0006878913,0.0002764439,0.0001852731,0.0002729776,0.000479862,0.9880959,0.00003468043],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"other","genre_gemma":"other","genre_scores_codex":[0.01629095,0.03422902,0.003011302,0.1418036,0.08705026,0.003320657,0.2483796,0.00268697,0.4632275],"genre_scores_gemma":[0.09271156,0.07556431,0.01178052,0.09611373,0.07218307,0.004836581,0.1061989,0.001758978,0.5388524],"genre_candidate":"other","genre_consensus":"other","teacher_disagreement_score":0.2606423,"threshold_uncertainty_score":0.8719353,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4243114708","doi":"10.2217/vjbm-2020-0011","title":"Designing and developing therapeutic proteins with Jumi Shin ","year":2020,"lang":"en","type":"article","venue":"Video Journal of Biomedicine","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"University of Toronto","funders":"","keywords":"Engineering ethics; Perspective (graphical); Work (physics); Management science; Data science; Sociology; Engineering; Computer science; Artificial intelligence; Mechanical engineering","authors":[{"name":"Jumi A. Shin","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05569858185442358,"gpt":0.3105407987522962,"spread":0.2548422168978727,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001590385,0.0008306345,0.000368514,0.0004017285,0.001026966,0.001573309,0.0006220817,0.001256525,0.006074464],"category_scores_gemma":[0.001106753,0.0004691777,0.0005070722,0.0003437613,0.001216462,0.001923302,0.001340303,0.003525728,0.002711727],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009980449,"about_ca_system_score_gemma":0.000864607,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00116355,"about_ca_topic_score_gemma":0.002296891,"domain_scores_codex":[0.9994457,0.0001326467,0.00001797706,0.0001099114,0.0002266344,0.00006710945],"domain_scores_gemma":[0.9996325,0.000091796,0.00002865027,0.00001623175,0.00007888075,0.0001520034],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0008910586,0.0002793983,0.0008406861,0.001726678,0.00008460322,0.001435971,0.003161836,0.002231028,0.3870321,0.08780229,0.253776,0.2607384],"study_design_scores_gemma":[0.00005827177,0.0003035663,0.0002552664,0.000163753,0.00003333004,0.0007582154,0.0004481424,0.001206332,0.07018684,0.006161068,0.9203757,0.00004943678],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"methods","genre_gemma":"empirical","genre_scores_codex":[0.06692214,0.2257924,0.3394484,0.1215675,0.04131254,0.0005554816,0.0005348368,0.005151995,0.1987147],"genre_scores_gemma":[0.2272325,0.1563375,0.2737054,0.03423408,0.007611849,0.0006316132,0.0007971976,0.001374792,0.298075],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.006074464,"threshold_uncertainty_score":0.02032107,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}